. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useDaunorubicin/administration & dosageDaunorubicin/therapeutic useDrug ApprovalDrug CarriersHIV Infections/complicationsHumansLiposomesQuality of LifeSarcoma, Kaposi/complicationsSarcoma, Kaposi/drug therapyTreatment OutcomeUnited StatesUnited States Food and Drug Administration
Substances: See more » Antineoplastic AgentsDrug CarriersLiposomesDaunorubicin
Year: 1996 PMID: 11363534
Source DB: PubMed Journal: J Int Assoc Physicians AIDS Care ISSN: 1081-454X